Alkermes (ALKS) Interest Expenses (2010 - 2026)
Alkermes (ALKS) posted quarterly Interest Expenses of $115.7 million for Q2 2026, up 4350.0% year-over-year from $2.6 million in Q2 2025, and little changed quarter-over-quarter from $115.6 million in Q1 2026.
Alkermes (ALKS) Interest Expenses (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Interest Expenses for 17 consecutive years, with $115.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Interest Expenses rose 4350.0% year-over-year to $115.7 million; the TTM figure through Jun 2026 stood at $115.7 million (up 1299.03% YoY), while the FY2025 annual figure was $89.8 million, down 9.54% from the prior year.
- Interest Expenses held at $115.7 million in Q2 2026 per ALKS's latest filing, from $115.6 million in the prior quarter.
- Across five years, Interest Expenses topped out at $115.7 million in Q2 2026 and bottomed at -$2.8 million in Q4 2024.
- Historically, Interest Expenses has averaged $17.2 million across 5 years, with a median of $5.5 million in 2023.
- Annual changes were most pronounced in 2024 — Interest Expenses sank 139.31% — and 2026, when it jumped 4524.0%.
- Alkermes' Interest Expenses stood at $4.8 million in 2022, then soared by 50.98% to $7.2 million in 2023, then tumbled by 139.31% to -$2.8 million in 2024, then jumped by 533.82% to $12.3 million in 2025, then soared by 842.41% to $115.7 million in 2026.
- Business Quant data shows ALKS's Interest Expenses at $115.7 million in Q2 2026, $115.6 million in Q1 2026, and $12.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 25.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 115.70 Mn |
| Jun 30, 2026 | 115.70 Mn |
| Mar 31, 2026 | 115.60 Mn |
| Mar 31, 2026 | 115.60 Mn |
| Dec 31, 2025 | 12.28 Mn |
| Dec 31, 2025 | 12.28 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | 5.98 Mn |
| Mar 31, 2024 | 5.98 Mn |